Onward

About:

Onward develops an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools.

Top Investors: Runway Growth Capital, Venture Kick, European Innovation Council, EQT Life Sciences, Invest-NL

Description:

Onward is developing an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools to rehabilitate patients suffering from neurological disorders such as spinal cord injury (SCI).

Total Funding Amount:

$208M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Eindhoven, Noord-Brabant, The Netherlands

Founded Date:

2014-01-01

Contact Email:

info(AT)gtxmedical.com

Founders:

Grégoire Courtine, Sjaak Deckers, Vincent Delattre

Number of Employees:

101-250

Last Funding Date:

2024-11-19

IPO Status:

Public

Industries: